VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $532,191 | -31.9% | 136,986 | +1.2% | 0.03% | -28.3% |
| Q2 2023 | $781,033 | -11.2% | 135,361 | 0.0% | 0.05% | -23.3% |
| Q1 2023 | $879,847 | +134.6% | 135,361 | -0.7% | 0.06% | +114.3% |
| Q4 2022 | $374,993 | -4.6% | 136,361 | +1.3% | 0.03% | -3.4% |
| Q3 2022 | $393,000 | +51.7% | 134,661 | 0.0% | 0.03% | +52.6% |
| Q2 2022 | $259,000 | -76.1% | 134,661 | +0.9% | 0.02% | -68.9% |
| Q1 2022 | $1,082,000 | -11.3% | 133,411 | +0.2% | 0.06% | -11.6% |
| Q4 2021 | $1,220,000 | -26.7% | 133,211 | +0.0% | 0.07% | -37.3% |
| Q3 2021 | $1,665,000 | +10.9% | 133,161 | +0.2% | 0.11% | +4.8% |
| Q2 2021 | $1,502,000 | -25.4% | 132,961 | 0.0% | 0.10% | -34.0% |
| Q1 2021 | $2,014,000 | +31.6% | 132,961 | 0.0% | 0.16% | +14.4% |
| Q4 2020 | $1,530,000 | +48.7% | 132,961 | 0.0% | 0.14% | +26.4% |
| Q3 2020 | $1,029,000 | -29.4% | 132,961 | +0.5% | 0.11% | -40.2% |
| Q2 2020 | $1,457,000 | +0.7% | 132,361 | 0.0% | 0.18% | -19.7% |
| Q1 2020 | $1,447,000 | -31.2% | 132,361 | 0.0% | 0.23% | -21.0% |
| Q4 2019 | $2,103,000 | – | 132,361 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,410,412 | $55,419,000 | 1.48% |
| Asymmetry Capital Management, L.P. | 76,885 | $1,249,000 | 1.15% |
| Fosun International Ltd | 794,279 | $12,907,000 | 0.62% |
| Orbimed Advisors | 1,479,733 | $24,046,000 | 0.29% |
| SPHERA FUNDS MANAGEMENT LTD. | 117,000 | $1,901,000 | 0.22% |
| Capital Investment Advisory Services, LLC | 10,700 | $174,000 | 0.08% |
| PURA VIDA INVESTMENTS, LLC | 20,000 | $325,000 | 0.07% |
| CONNING INC. | 129,013 | $2,096,000 | 0.06% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 215,145 | $3,496,000 | 0.06% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 34,812 | $566,000 | 0.03% |